Understanding Maintenance on GLP-1 Medications

Welcome back to the Doc2Lift podcast! I'm Dr. Spencer Nadolsky, your host, alongside co-host Dr. Karl Nadolsky, a super endocrinologist. In today's episode, we dive into the intricacies of maintaining weight after using GLP-1 medications. We will discuss whether to stay on the highest dose, lower the dose, or even discontinue use altogether. We will also cover the insights from two recent studies presented at the conference and how these findings apply to our clinical practice.

The Challenge of Weight Maintenance

Obesity is a complex disease, often misunderstood. Many patients believe that simply losing weight is enough to maintain health, but the reality is that weight maintenance is challenging due to various biological and environmental factors. In fact, recent studies indicate that over half of the weight lost in diet and exercise trials is typically regained.

According to the SURMOUNT-4 trial, participants who lost an average of 21% of their weight were randomized to either continue the treatment or switch to a placebo. The results demonstrated that while some maintained their weight loss, others struggled significantly, highlighting the biological factors working against weight maintenance.

Insights from Recent Studies

Two new studies have been released that provide further insight into GLP-1 medications:

• Attain Maintain: This study evaluated the use of orforglipron after treatment with semaglutide or tirzepatide.
• SURMOUNT-MAINTAIN: This study investigated the effects of lowering the dose of tirzepatide after patients had been on a maximum tolerated dose.

These randomized controlled trials are invaluable, as they help us understand the effects of GLP-1 medications across large populations, providing a clearer picture of their effectiveness and maintenance strategies.

Clinical Approach to Maintenance

In our clinical practice, we emphasize the importance of individualized plans for our patients. While some may wish to lower their medication doses or discontinue use, it is crucial to monitor their progress closely.

• Patients should ideally remain on the maximum tolerated dose, especially if insurance covers it.
• For those experiencing side effects or financial burdens, a lower dose may be considered.
• Regular check-ins and support are necessary to address any weight regain and to provide additional interventions if needed.

It is essential to avoid the cycle of stopping medication prematurely, which can lead to weight regain and health complications.

The Impact of Biological and Environmental Factors

As discussed, maintaining weight involves more than just medication; it requires understanding the biological factors at play. These include metabolic adaptation and the influence of our obesogenic environment, which can lead to weight regain regardless of prior successes in weight loss.

For individuals who regain weight, it is vital to explore potential underlying conditions, such as thyroid issues or other hormonal imbalances, and to consider the role of lifestyle factors in their overall health.

Conclusion

In conclusion, while GLP-1 medications such as tirzepatide and semaglutide can significantly aid in weight loss, they are not a one-size-fits-all solution. Maintenance requires a personalized approach that considers each patient's unique situation and challenges. As healthcare providers, our role is to support our patients in navigating their weight management journey effectively.

Don't forget to stay tuned for our next episode, where we'll continue to explore the latest in health and wellness!